Transgene SA (LTS:0OCQ) Transcripts
Half Year 2024 Transgene SA Earnings Call Transcript
Sep 24, 2024
€1.12
Earnings
Full Year 2023 Transgene SA Earnings Call Transcript
Mar 27, 2024
€1.1
Earnings
Half Year 2023 Transgene SA Earnings Call Transcript
Sep 20, 2023
€1.81
(-0.66%)
Earnings
Transgene SA Conference Call Transcript
May 05, 2023
Full Year 2022 Transgene SA Earnings Call Transcript
Mar 16, 2023
€2.01
Earnings
Transgene SA Interim Analysis of TG4001 Phase II Trial Call Transcript
Nov 02, 2022
Transgene SA R&D Day Transcript
Sep 27, 2022
Q2 2022 Transgene SA Earnings Call Transcript
Sep 07, 2022
€2.12
Earnings
Q4 2021 Transgene SA Earnings Call Transcript
Mar 16, 2022
€2.18
(+1.40%)
Earnings
Transgene SA Corporate Call Transcript
Dec 15, 2021
Transgene SA TG4050 Phase I Studies Results Webcast Transcript
Nov 23, 2021
Q2 2021 Transgene SA Earnings Call Transcript
Sep 22, 2021
€2.58
Earnings
Transgene SA Presents Results From the Phase 1b/2 trial of TG4001 in Combination with Avelumab Conference Call Transcript
Nov 12, 2020
Transgene SA Results from Clinical Study of TG4001 in Combination with Avelumab Conference Call Transcript
Jul 22, 2020
Q4 2019 Transgene SA Earnings Call Transcript
Mar 11, 2020
€1.26
Earnings